02/14/2025
12:22 PM | Galera Therapeutics (Subject)
Ikarian Capital, LLC (Filed by)
| Form SCHEDULE 13G | |
01/24/2025
8:04 AM | Galera Therapeutics (Filer)
| Form DEF 14A | |
01/13/2025
8:44 PM | Galera Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
01/13/2025
2:18 PM | Galera Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
01/02/2025
3:12 PM | CHANG NANCY T (Reporting)
Galera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2025
3:05 PM | FRIEDMAN MICHAEL R. (Reporting)
Galera Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2025
3:08 PM | FRIEDMAN MICHAEL R. (Reporting)
Galera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/31/2024
6:11 AM | Galera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/20/2024
3:42 PM | Galera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/13/2024
6:17 AM | Galera Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/15/2024
4:25 PM | Galera Therapeutics (Filer)
| Form NT 10-Q | |
Get the Latest News and Ratings for GRTX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Galera Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
10/18/2024
7:05 AM | Galera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/06/2024
6:38 AM | Galera Therapeutics (Subject)
Nasdaq Stock Market LLC (Filed by)
| Form 25-NSE | |
09/04/2024
6:01 AM | Galera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/03/2024
6:00 AM | Galera Therapeutics (Filer)
| Form DEF 14A | |
08/23/2024
6:00 AM | Galera Therapeutics (Filer)
| Form PRE 14A | |
08/20/2024
3:45 PM | Galera Therapeutics (Issuer)
Sorensen Mel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
11:52 AM | Galera Therapeutics (Subject)
Sorensen Mel (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2024
6:30 AM | Galera Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/14/2024
6:05 AM | Galera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2024
6:10 AM | Galera Therapeutics (Subject)
| Form 425 | |
08/08/2024
6:00 AM | Galera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2024
6:02 AM | Galera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/03/2024
6:00 AM | Galera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/16/2024
9:25 AM | Galera Therapeutics (Subject)
Soffer Rochel (Filed by)
| Form SC 13G | |
05/16/2024
9:26 AM | Galera Therapeutics (Subject)
Schneid Yair (Filed by)
| Form SC 13G/A | |
05/16/2024
9:26 AM | ALPHA PHARMA Investments LLC (Reporting)
Galera Therapeutics (Issuer)
Soffer Rochel (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/13/2024
6:30 AM | Galera Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/13/2024
6:05 AM | Galera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/03/2024
3:07 PM | Galera Therapeutics (Filer)
| Form 8-A12B | |
05/01/2024
4:02 PM | Galera Therapeutics (Issuer)
Schneid Yair (Reporting)
| Form 4/A | |
04/16/2024
3:39 PM | ALPHA PHARMA Investments LLC (Filed by)
Galera Therapeutics (Subject)
| Form SC 13G | |
04/03/2024
7:08 AM | Altamont Pharmaceutical Holdings, LLC (Filed by)
Galera Therapeutics (Subject)
| Form SC 13G/A | |
04/01/2024
8:36 PM | Altamont Pharmaceutical Holdings, LLC (Reporting)
Galera Therapeutics (Issuer)
Pearson Mark E. (Reporting)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
03/28/2024
6:30 AM | Galera Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/28/2024
6:06 AM | Galera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/27/2024
6:31 AM | Galera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Free GRTX Stock Alerts